Global Liquid Biopsy Market Report 2022-2028: Competitive

Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) — The “Global Liquid Biopsy Market – Analysis by Biomarker Type (CTCs, ctDNA, EVs, Others), Product (Assay Kits, Instruments and Devices, Services), By Indication By Region , By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)” report has been added to’s offering.The Global Liquid Biopsy Market was valued at USD 2.2 Billion in the year 2021 backed by Several initiatives to raise cancer awareness launched by governments and global health organizations over the last decade. The report presents the analysis of the Liquid Biopsy market for the historical period of 2018-2021 and the forecast period of 2023-2028. Developing economies such as India, China, South Korea, Brazil, Turkey, Russia, and South Africa are expected to provide potential growth opportunities for liquid biopsy market players. This can be attributed to these countries’ higher cancer prevalence, large patient populations, improved healthcare infrastructure, rising disposable income, and growing medical tourism. Apart from the previously mentioned factors, the Asia Pacific region has emerged as an adaptable and business-friendly hub due to less stringent regulations and data requirements. Assay kits are essential for detecting cancer tumor cells or tumor DNA using liquid biopsy. Liquid biopsy assays are low-cost, minimally invasive procedures that aid in patient monitoring during and after treatment and screening. Other major factors driving the growth of the liquid biopsy assay kits market include the availability of a wide range of reagents and kits, easy access to a wide range of assays, and the rising prevalence of cancer. The high adoption of advanced technologies such as NGS , the increasing number of research studies for the discovery and development of novel cancer biomarkers, the presence of many pharmaceutical companies, rising funding and investments from public and private organizations, and the increasing use of biomarkers in patient stratification and drug development processes are driving growth in North America’s developed markets. The report tracks competitive developments, strategies, mergers, and acquisitions, and new Biomarker development. Key Metrics Report Attribute Details No. of Pages260Forecast Period2022 – 2028Estimated Market Value (USD) in 2022$1.75 BillionForecasted Market Value (USD) by 2028$4.78 BillionCompound Annual Growth Rate18.2%Regions CoveredGlobal Competitive Positioning Companies’ Product PositioningMarket Position MatrixMarket Share Analysis in Market ofCompanyProfilesLiquid analysis the report includes Roche Holding AGAbbott LaboratoriesIllumina Inc.BiocartisGuardant HealthQIAGENThermo Fisher ScientificBiocept, Inc.Bio-Rad LaboratoriesMDxHealth Key Topics Covered:1. Introduction1.1 Liquid Biopsy Market Overview1.2 Scope of Research2. Executive Summary2.1 Market Snapshot2.2 Regional Insights2.3 Market Ecosystem Factors3. Research Methodology3.1 Data Collection Process3.2 Market Trajectory Estimation3.3 Market Size Calculation-Top-to-Bottom4 Market Dynamics4.1 Drivers4.2 Restraints4.3 Opportunities4.4 Analyst Recommendations4.5 Trends4.6 Impact Analysis5. Value Chain Analysis5.1 Value Chain Analysis of Liquid Biopsy Market6 COVID-19 Impact Assessment6.1 Degree of Impact of COVID-19 on Liquid Biopsy Market6.2 Region-Wise Quarterly Covid Impact Analysis (2020)7 Porter’s five forces analysis8 Macro Economic Indicator Outlook8.1 GDP per capita growth (annual %)8.2 Global Medical Spending in 2020, By Region, (% of Total)8.3 Current Healthcare Expenditure8.4 Pharmaceutical Spending/capita8.5 Cancer Incidence9 Global Liquid Biopsy Market9.1 Impact Analysis of Macro Economic Factors on Liquid Biopsy Market9.2 Snapshot9.3 Global Liquid Biopsy Market: Market Value Assessment9.4 Market Summary10. Global Liquid Biopsy Market Trend And Forecast Analysis, 2018-2028, By Biomarker Type10.1 Global Liquid Biopsy Market Trend And Forecast Analysis, Biomarker Type: Snapshot10.2 Circulating tumor cells (CTCs)10.3 Circulating tumor DNA (ctDNA)10.4 Extracellular vesicles10. 5Other Biomarkers11. Global Liquid Biopsy Market Trend And Forecast Analysis, 2018-2028, By Indication11.1 Global Liquid Biopsy Market Trend And Forecast Analysis, By Indication: Snapshot11.2 Cancer11.3 Prenatal Screening11.4 Others12. Global Liquid Biopsy Market Trend And Forecast Analysis, 2018-2028, By Product12.1 Global Liquid Biopsy Market Trend And Forecast Analysis, By Product: Snapshot12.2 Assay Kits12.3 Instruments and Devices12.4 Services13. Global Liquid Biopsy Market Trend And Forecast Analysis, 2018-2028, By Region13.1 Regional Coverage of the Study For more information about this report visit About ResearchAndMarkets. is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Global Liquid Biopsy Market

Leave a Comment

Your email address will not be published. Required fields are marked *